These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8289419)

  • 1. A comparison of medium-chain and long-chain triglycerides in surgical patients.
    Goldstein RE
    JPEN J Parenter Enteral Nutr; 1993; 17(5):481-2. PubMed ID: 8289419
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oxidative utilization of 13C-labeled medium-chain triglycerides in respiratory intensive care patients].
    Adolph M; Eckart J; Metges C; Neeser G; Wolfram G
    Beitr Infusionther Klin Ernahr; 1988; 20():126-44. PubMed ID: 3132140
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of MCT-containing fat emulsions in stress conditions].
    Jauch KW; Hailer S
    Beitr Infusionther Klin Ernahr; 1988; 20():145-55. PubMed ID: 3132141
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of LCT- and MCT-containing fat emulsions in liver cirrhosis].
    Leweling H; Tschepe A; Staedt U; Gladisch R; Holm E
    Beitr Infusionther Klin Ernahr; 1988; 20():165-78. PubMed ID: 3132142
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medium-chain triglycerides in parenteral nutrition in children].
    Arch Fr Pediatr; 1993 Mar; 50(3):267-9. PubMed ID: 8338423
    [No Abstract]   [Full Text] [Related]  

  • 6. Medium chain triglycerides and structured lipids as unique nonglucose energy sources in hyperalimentation.
    Mascioli EA; Bistrian BR; Babayan VK; Blackburn GL
    Lipids; 1987 Jun; 22(6):421-3. PubMed ID: 3112487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of the nutritional condition on the utilization of MCT and LCT in the rat model].
    Bender R; Stehle P; Fürst P
    Beitr Infusionther Klin Ernahr; 1988; 20():20-35. PubMed ID: 3132144
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic effects of structured triglycerides in humans.
    Hyltander A; Sandström R; Lundholm K
    Nutr Clin Pract; 1995 Jun; 10(3):91-7. PubMed ID: 7616934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fat emulsions containing medium chain triglycerides in parenteral nutrition of intensive care patients.
    Eckart J; Adolph M; van der Mühlen U; Naab V
    JPEN J Parenter Enteral Nutr; 1980; 4(4):360-6. PubMed ID: 6774117
    [No Abstract]   [Full Text] [Related]  

  • 10. New developments in fat emulsions.
    Carpentier YA; Richelle M; Haumont D; Deckelbaum RJ
    Proc Nutr Soc; 1990 Oct; 49(3):375-80. PubMed ID: 2127850
    [No Abstract]   [Full Text] [Related]  

  • 11. Medium-chain triglycerides (MCT) for total parenteral nutrition.
    Wolfram G
    World J Surg; 1986 Feb; 10(1):33-7. PubMed ID: 3083598
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of MCT-containing fat emulsions on postoperative protein metabolism].
    Löhlein D; Haessner J
    Beitr Infusionther Klin Ernahr; 1988; 20():156-64. PubMed ID: 3288189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Elimination and metabolism of MCT-containing fat emulsions in postoperative patients in the framework of total parenteral nutrition].
    Herrmann A; Jauch KW; Günther B; Schildberg FW
    Infusionstherapie; 1990 Aug; 17(4):185-90; 193-6. PubMed ID: 2120133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic consequences of infusing emulsions containing medium chain triglycerides for parenteral nutrition: a comparative study with conventional lipid.
    Dennison AR; Ball M; Crowe PJ; White K; Hands L; Watkins RM; Kettlewell M
    Ann R Coll Surg Engl; 1986 May; 68(3):119-21. PubMed ID: 3089123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat elimination in acute renal failure.
    Sultan F; Mauriac C
    Am J Clin Nutr; 1993 Aug; 58(2):242-3. PubMed ID: 8338052
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and metabolic tolerance of a concentrated long-chain triglyceride lipid emulsion in critically ill septic and trauma patients.
    García-de-Lorenzo A; López-Martínez J; Planas M; Chacón P; Montejo JC; Bonet A; Ortiz-Leyba C; Sánchez-Segura JM; Ordóñez J; Acosta J; Grau T; Jiménez FJ
    JPEN J Parenter Enteral Nutr; 2003; 27(3):208-15. PubMed ID: 12757115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic response to intravenous medium-chain triglycerides in infants after surgery.
    Donnell SC; Lloyd DA; Eaton S; Pierro A
    J Pediatr; 2002 Nov; 141(5):689-94. PubMed ID: 12410199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a medium-chain triacylglycerol/long-chain triacylglycerol fat emulsion containing a reduced ratio of phospholipid to triacylglycerol in pediatric surgical patients.
    Lai HS; Lin WH; Wu HC; Chang KJ; Chen WJ
    Nutrition; 2005; 21(7-8):825-30. PubMed ID: 15975490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New parenteral substrates in clinical nutrition. Part II. New substrates in lipid nutrition.
    Fürst P
    Eur J Clin Nutr; 1994 Oct; 48(10):681-91. PubMed ID: 7835323
    [No Abstract]   [Full Text] [Related]  

  • 20. [Randomized study comparing long-chain (LCT) and medium-chain (MCT) triglycerides as caloric carriers in postoperative nutritional therapy].
    Lünstedt B; Deltz E; Kähler M; Bruhn A
    Infusionsther Klin Ernahr; 1987 Apr; 14(2):61-4. PubMed ID: 3112002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.